Paper8313355
Transforming growth factor-alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE38) treatment of subcutaneous and intracranial human glioma and medulloblastoma xenografts in athymic mice.
Phillips PC and 5 others. Cancer Res, 1994. Cited by 76 papers, by iCite.
Cite this record
ConductScience Library. Transforming growth factor-alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE38) treatment of subcutaneous and intracranial human glioma and medulloblastoma xenografts in athymic mice. Papers, record 8313355. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8313355
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Transforming growth factor-alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE38) treatment of subcutaneous and intracranial human glioma and medulloblastoma xenografts in athymic mice.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Brain Neoplasms | Major topic |
| Exotoxins | Major topic |
| Glioma | Major topic |
| Medulloblastoma | Major topic |
| Recombinant Fusion Proteins | Major topic |
| Transforming Growth Factor alpha | Major topic |
| Animals | |
| ErbB Receptors | |
| Female | |
| Humans | |
| Mice | |
| Mice, Nude | |
| Neoplasm Transplantation | |
| Transplantation, Heterologous | |
| Tumor Cells, Cultured |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA 52857 | NCI NIH HHS | United States | U01CA052857 | PubMed and NIH | NIH RePORTER |
| NS01279 | NINDS NIH HHS | United States | K08NS001279 | PubMed and NIH | NIH RePORTER |
| NS31102 | NINDS NIH HHS | United States | P20NS031102 | PubMed and NIH | NIH RePORTER |
| U19CA052857 | NIH | NIH RePORTER |
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 76 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41998209 | Antitumor immunotoxin expression is enhanced by Escherichia coli csrB-promoter activity. | Oncogene | 2026 | https://conductscience.org/library/papers/41998209 | PubMed |
| 33738260 | Use of Salmonella Bacteria in Cancer Therapy: Direct, Drug Delivery and Combination Approaches. | Front Oncol | 2021 | https://conductscience.org/library/papers/33738260 | PubMed |
| 33603862 | MicroRNA-34b-5p inhibits proliferation, stemness, migration and invasion of retinoblastoma cells via Notch signaling. | Exp Ther Med | 2021 | https://conductscience.org/library/papers/33603862 | PubMed |
| 28752098 | Recombinant Immunotoxin Therapy of Glioblastoma: Smart Design, Key Findings, and Specific Challenges. | Biomed Res Int | 2017 | https://conductscience.org/library/papers/28752098 | PubMed |
| 28473665 | Anti-tumor activity of an immunotoxin (TGFα-PE38) delivered by attenuated Salmonella typhimurium. | Oncotarget | 2017 | https://conductscience.org/library/papers/28473665 | PubMed |
| 27153091 | Immunotoxin Therapies for the Treatment of Epidermal Growth Factor Receptor-Dependent Cancers. | Toxins (Basel) | 2016 | https://conductscience.org/library/papers/27153091 | PubMed |
| 25684137 | Design of an EGFR-targeting toxin for photochemical delivery: in vitro and in vivo selectivity and efficacy. | Oncogene | 2015 | https://conductscience.org/library/papers/25684137 | PubMed |
| 24932299 | TGFα-PE38 enhances cytotoxic T-lymphocyte killing of breast cancer cells. | Oncol Lett | 2014 | https://conductscience.org/library/papers/24932299 | PubMed |
| 24294521 | An update in the use of antibodies to treat glioblastoma multiforme. | Autoimmune Dis | 2013 | https://conductscience.org/library/papers/24294521 | PubMed |
| 22400035 | Toxin-based targeted therapy for malignant brain tumors. | Clin Dev Immunol | 2012 | https://conductscience.org/library/papers/22400035 | PubMed |
| 22069569 | Targeted toxins in brain tumor therapy. | Toxins (Basel) | 2010 | https://conductscience.org/library/papers/22069569 | PubMed |
| 21707497 | Targeted toxins for glioblastoma multiforme: pre-clinical studies and clinical implementation. | Anticancer Agents Med Chem | 2011 | https://conductscience.org/library/papers/21707497 | PubMed |
| 21453286 | Gene therapy and targeted toxins for glioma. | Curr Gene Ther | 2011 | https://conductscience.org/library/papers/21453286 | PubMed |
| 20415598 | Investigational EGFR-targeted therapy in head and neck squamous cell carcinoma. | Expert Opin Investig Drugs | 2010 | https://conductscience.org/library/papers/20415598 | PubMed |
| 18403491 | Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors. | Neuro Oncol | 2008 | https://conductscience.org/library/papers/18403491 | PubMed |
| 16457645 | Gene therapy and targeted toxins for glioma. | Curr Gene Ther | 2005 | https://conductscience.org/library/papers/16457645 | PubMed |
| 16248789 | Combining cytotoxic and immune-mediated gene therapy to treat brain tumors. | Curr Top Med Chem | 2005 | https://conductscience.org/library/papers/16248789 | PubMed |
| 16133418 | Clinical significance of EGFR amplification and the aberrant EGFRvIII transcript in conventionally treated astrocytic gliomas. | J Mol Med (Berl) | 2005 | https://conductscience.org/library/papers/16133418 | PubMed |
| 15509485 | Targeted molecular therapy for malignant gliomas. | Curr Treat Options Oncol | 2004 | https://conductscience.org/library/papers/15509485 | PubMed |
| 14649884 | Interleukin-13 receptor-directed cytotoxin for malignant glioma therapy: from bench to bedside. | J Neurooncol | 2003 | https://conductscience.org/library/papers/14649884 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| EGF | 1950 | PubTator's text mining | https://conductscience.org/library/genes/1950 | NCBI Gene |
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
| TGFA | 7039 | PubTator's text mining | https://conductscience.org/library/genes/7039 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8313355
GET https://conductscience.org/api/papers/v1/8313355/cited_by?page=2